3546 results for «231»

Filter By

3546 results

Minimalist approach to tricuspid valve therapy

11 Sep 2025 – From PCR Rio Valves 2025

This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...

Minimalist approach to tricuspid valve therapy

Transcatheter tricuspid valve replacement - Where are we in Latin America?

12 Sep 2025 – From PCR Rio Valves 2025

Stay abreast of the latest advances in transcatheter tricuspid valve replacement (TTVR) across Latin America. This session highlights orthotopic implant technologies, patient selection criteria, early clinical outcomes, and discusses future perspectives including training, technology access, and regional clinical impact.

Transcatheter tricuspid valve replacement - Where are we in Latin America?

PCR Tokyo Valves 2025: Your travel guide featuring upcoming exclusive booking services and special deals.

Join us in Tokyo from 7-9 February: Explore the Toranomon Hills Tower venue and stay updated on the best deals for flights and hotel accommodations.

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

The impact of COVID-19 pandemic on interventional cardiologists in training

23 Oct 2020

In collaboration with EuroIntervention Journal

The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...

The impact of COVID-19 pandemic on interventional cardiologists in training
Didn’t find what you were looking for?